Offering Choice of CRC Screening Increases Completion Rates
By Elana Gotkine HealthDay Reporter
TUESDAY, May 21, 2024 -- For adults who are not up to date with colorectal cancer screening, offering a choice of colonoscopy or fecal immunochemical testing (FIT) increases screening completion rates, according to a study published online April 30 in Clinical Gastroenterology and Hepatology.
Shivan J. Mehta, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted a randomized controlled trial at a community health center among patients aged 50 to 74 years who were not up to date with CRC screening. Patients were randomly assigned to receive colonoscopy only, active choice of colonoscopy or FIT, or FIT only in a 1:1:1 ratio. Participants received an outreach letter with testing instructions, a reminder letter at two months, and another reminder at three to five months.
The final analysis included 738 patients (mean age, 58.7 years). The researchers found that at six months, 5.6, 12.8, and 11.3 percent of participants had completed screening in the colonoscopy-only, active choice, and FIT-only arms, respectively. There was a significant increase in screening observed in the active choice and FIT-only arms compared with the colonoscopy-only arm.
"Offering the choice of colonoscopy or take-home kits [seems] to have the advantage of maximizing the rates of colonoscopy -- the most effective screening tool -- while not overloading individuals with too much of a choice, which could have lowered overall participation," Mehta said in a statement.
Several authors disclosed ties to industry, including one who is a named inventor on a patent licensed to Novartis.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
FRIDAY, June 28, 2024 -- Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National...
PIK3CA Could Guide Use of COX-2 Inhibitors in Treatment for Colon Cancer
THURSDAY, June 27, 2024 -- PIK3CA mutational status may be beneficial for predicting response to addition of the cyclooxygenase 2 (COX-2) inhibitor celecoxib to standard adjuvant...
GLP-1 RA Use Linked to Lower Quality of Bowel Preparation
THURSDAY, June 13, 2024 -- The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.